Patients who are receiving antiplatelet and/or anticoagulant therapy with bleeding complications. Circulatory System
Conditions
Interventions
Our study is a prospective, multicenter, registry study. We plan to invite several centers to the register, including several departments with different profiles - including surgical and non-surgical
Sponsors
MezzoCardio
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age over 18 years 2. Gender – women and men 3. Patients receiving anticoagulant and/or antiplatelet therapy hospitalized in non-cardiac departments with a complication of treatment in the form of bleeding.
Exclusion criteria
Exclusion criteria: 1. Age under 18 years of age 2. Lack of consent to participate in the register
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Basic clinical data on risk factors collected upon admission to hospital, upon discharge and one month after hospitalization: 1. Cardiovascular risk 2. Risk of bleeding 3. Thrombosis 4. Multi-morbidity 5. Indications and method of cardiac treatment (antiplatelet/anticoagulation) 6. Management of a patient undergoing cardiological treatment under planned conditions in the surgical ward 7. Leading symptoms of bleeding, location and degree of bleeding assessed based on the international BARC scale 8. In-hospital diagnostics 9. Management of bleeding 10. Length of hospitalization 11. Possible change of cardiac treatment after bleeding and prognosis in patients with bleeding complications | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
Poland
Contacts
Public ContactDamian Kawecki
Outcome results
None listed